A study comparing the effect and safety of once weekly dosing of somapacitan with daily Norditropin® as well as evaluating long-term safety of somapacitan in a basket study design in children with short stature either born small for gestational age or with Turner syndrome, Noonan syndrome, or idiopathic short stature

drug protocol number

NN8640-4467

drug sponsor

Novo Nordisk

drug study

Sogroya , Norditropin

drug trial site

King Faisal Specialist Hospital and Research Center (Riyadh) , King Abdulaziz Medical City NG (Riyadh)

drug status

Ongoing

drug phase